THE SHARE: Change: 0.00 SEK (-3.57%) / Price: 0.11 SEK / Apr 16, 2026, 6:00 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

  • 16 Apr, 2013
    SPAGO Pix Properties Verified at MAX-Lab
  • 4 Apr, 2013
    Årsredovisning 2012
  • 26 Mar, 2013
    Kallelse till årsstämma i Spago Imaging AB (publ)
  • 22 Mar, 2013
    Moderbolaget Accelerator Nordic AB delar ut sitt innehav i SPAGO Imaging AB
  • 22 Feb, 2013
    Bokslutskommuniké Jan – december 2012
  • 9 Jan, 2013
    Sista dag för handel med BTA
  • 27 Dec, 2012
    The SPAGO BTAs are traded on AktieTorget
  • 11 Dec, 2012
    SPAGO’s issue of shares fully subscribed
  • 27 Nov, 2012
    Veckans Affärer: ” Håll koll på spännande avknoppning”
  • 12 Nov, 2012
    SPAGO Imaging Announces Memorandum for New Shares Issue
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • Previous
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications